Aspire Private Capital’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-675
| Closed | -$56.6K | – | 346 |
|
|
2024
Q3 | $56.6K | Buy |
675
+21
| +3% | +$1.76K | 0.01% | 224 |
|
|
2024
Q2 | $44.8K | Buy |
654
+133
| +26% | +$9.12K | 0.01% | 243 |
|
|
2024
Q1 | $38.2K | Buy |
521
+37
| +8% | +$2.71K | 0.01% | 257 |
|
|
2023
Q4 | $39.3K | Sell |
484
-70
| -13% | -$5.68K | 0.01% | 248 |
|
|
2023
Q3 | $41.5K | Sell |
554
-7
| -1% | -$525 | 0.01% | 229 |
|
|
2023
Q2 | $43.2K | Sell |
561
-136
| -20% | -$10.5K | 0.01% | 219 |
|
|
2023
Q1 | $57.8K | Sell |
697
-124
| -15% | -$10.3K | 0.02% | 191 |
|
|
2022
Q4 | $70.5K | Sell |
821
-52
| -6% | -$4.46K | 0.03% | 166 |
|
|
2022
Q3 | $54K | Sell |
873
-77
| -8% | -$4.76K | 0.02% | 186 |
|
|
2022
Q2 | $59K | Sell |
950
-24
| -2% | -$1.49K | 0.02% | 185 |
|
|
2022
Q1 | $58K | Sell |
974
-365
| -27% | -$21.7K | 0.02% | 196 |
|
|
2021
Q4 | $97K | Sell |
1,339
-228
| -15% | -$16.5K | 0.03% | 168 |
|
|
2021
Q3 | $109K | Sell |
1,567
-263
| -14% | -$18.3K | 0.04% | 157 |
|
|
2021
Q2 | $126K | Sell |
1,830
-2,783
| -60% | -$192K | 0.04% | 161 |
|
|
2021
Q1 | $298K | Sell |
4,613
-3,818
| -45% | -$247K | 0.1% | 112 |
|
|
2020
Q4 | $491K | Buy |
8,431
+1,582
| +23% | +$92.1K | 0.19% | 75 |
|
|
2020
Q3 | $433K | Buy |
6,849
+4,377
| +177% | +$277K | 0.18% | 77 |
|
|
2020
Q2 | $190K | Sell |
2,472
-4,922
| -67% | -$378K | 0.09% | 95 |
|
|
2020
Q1 | $553K | Buy |
7,394
+570
| +8% | +$42.6K | 0.3% | 54 |
|
|
2019
Q4 | $443K | Sell |
6,824
-156
| -2% | -$10.1K | 0.19% | 78 |
|
|
2019
Q3 | $442K | Buy |
6,980
+6,799
| +3,756% | +$431K | 0.21% | 74 |
|
|
2019
Q2 | $12K | Buy |
181
+53
| +41% | +$3.51K | 0.01% | 253 |
|
|
2019
Q1 | $8K | Hold |
128
| – | – | ﹤0.01% | 330 |
|
|
2018
Q4 | $8K | Buy |
+128
| New | +$8K | ﹤0.01% | 315 |
|